Fig. 10From: Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinomaDrug sensitivity analysis of nine TFs with trametinib. A Correlation between the expression levels of eight TFs and trametinib drug sensitivity. B The effects of the expression of core TFs on the IC50 value of trametinib. ***p < 0.001Back to article page